Aflac Incorporated (NYSE:AFL) announced a quarterly dividend on Wednesday, November 18th, RTT News reports. Investors of record on Wednesday, February 17th will be given a dividend of 0.33 per share by the financial services provider on Monday, March 1st. This represents a $1.32 dividend on an annualized basis and a yield of 3.02%. This is a boost from Aflac’s previous quarterly dividend of $0.28.
Aflac has raised its dividend payment by 30.1% over the last three years and has raised its dividend annually for the last 38 consecutive years. Aflac has a payout ratio of 23.0% meaning its dividend is sufficiently covered by earnings. Analysts expect Aflac to earn $4.83 per share next year, which means the company should continue to be able to cover its $1.12 annual dividend with an expected future payout ratio of 23.2%.
NYSE AFL opened at $43.72 on Friday. Aflac has a 12 month low of $23.07 and a 12 month high of $55.07. The company has a debt-to-equity ratio of 0.24, a current ratio of 0.06 and a quick ratio of 0.06. The company has a market capitalization of $30.71 billion, a price-to-earnings ratio of 6.83, a price-to-earnings-growth ratio of 1.75 and a beta of 0.81. The company’s fifty day moving average price is $37.76 and its two-hundred day moving average price is $36.71.
Aflac (NYSE:AFL) last posted its quarterly earnings data on Sunday, November 1st. The financial services provider reported $1.39 EPS for the quarter, beating the Zacks’ consensus estimate of $1.14 by $0.25. Aflac had a net margin of 21.11% and a return on equity of 12.12%. During the same quarter in the prior year, the business posted $1.16 EPS. As a group, analysts anticipate that Aflac will post 4.93 EPS for the current year.
AFL has been the topic of a number of research analyst reports. Morgan Stanley increased their price objective on shares of Aflac from $48.00 to $49.00 and gave the company an “equal weight” rating in a research note on Wednesday. TheStreet upgraded shares of Aflac from a “c+” rating to a “b-” rating in a research note on Wednesday, October 7th. ValuEngine downgraded shares of Aflac from a “sell” rating to a “strong sell” rating in a research note on Monday, August 3rd. SunTrust Banks reduced their price target on shares of Aflac from $44.00 to $37.00 and set a “hold” rating on the stock in a research report on Thursday, July 30th. Finally, Credit Suisse Group raised their price target on shares of Aflac from $35.00 to $40.00 and gave the stock a “neutral” rating in a research report on Tuesday, September 22nd. One investment analyst has rated the stock with a sell rating, seven have given a hold rating and two have issued a buy rating to the company. The company presently has an average rating of “Hold” and an average price target of $43.63.
Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers cancer, medical, income support, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products.
Further Reading: G-20
Receive News & Ratings for Aflac Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aflac and related companies with MarketBeat.com's FREE daily email newsletter.